Hypersecretion of luteinising hormone, infertility, and miscarriage

The Lancet

Volumn 336, Issue 8724, 1990, Pages 1141-1144

  Regan, L ^a   Owen, E J ^b   Jacobs, H S ^b  

^a Rosie Maternity Hospital   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE;

ARTICLE; FEMALE; HORMONE RELEASE; HUMAN; INFERTILITY; PREGNANCY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; ADULT; BLOOD; EPIDEMIOLOGY; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLOW UP; NEWBORN; PHYSIOLOGY; PREGNANCY COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT ABORTION;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADULT; BIAS (EPIDEMIOLOGY); EVALUATION STUDIES; FEMALE; FOLLICULAR PHASE; FOLLOW-UP STUDIES; HUMAN; INFANT, NEWBORN; INFERTILITY, FEMALE; LUTEINIZING HORMONE; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0025194669     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)92765-A     Document Type: Article

References (29)

1. Incidence of early loss of pregnancy
2. Occult biochemical pregnancy: fact or fiction?
3. Influence of past reproductive performance on risk of spontaneous abortion
4. Some endocrinological events associated with early pregnancy failure
5. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients
6. Is the polycystic ovary a cause of infertility in the ovulatory woman?
7. The diagnosis of polycystic ovaries in subfertile women
8. Polycystic ovaries: a common finding in normal women
9. Recommended definitions, terminology and format for statistical tables related to the perinatal period
10. Double blind study of the effect of 17-hydroxyprogesterone caproated on abortion rate
11. Endocrine effects of 17 alpha hydroxyprogesterone caproate during early pregnancy: a double blind clinical trial
12. Progress and problems in immunoassays for serum pituitary gonadotrophin; evidence from the UK External Quality Assessment Scheme (EQAS 1980-1988)
13. Measuring serum gonadotropins: a cautionary note
14. Etiology of miscarriage in polycystic ovary syndrome
15. Recurrent early miscarriage and polycystic ovaries
16. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation
17. The endocrinology of conception
18. Local nonsteroidal regulators of ovarian function
19. Oogenesis and ovulation
20. Dissociation of response to injected gonadotrophin between the Graafian follicle and oocyte in pigs
21. The egg
22. Spontaneous abortion and aging of human ova and spermatozoa
23. Reduced in-vitro fertilisation of human oocytes from patients with raised basal LH levels during the follicular phase
24. Effect of high tonic luteinising hormone on outcome of in-vitro fertilisation
25. Spontaneous luteinising hormone surge and cleavage of in vitro fertilised embryos
26. Do raised serum luteinising hormone levels during stimulation for in vitro fertilisation predict outcome?
27. Influence of serum luteinising hormone concentrations on ovulation conception and early pregnancy loss in polycystic ovary syndrome
28. Combined luteinising hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries
29. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome